CYBEROPTICS CORP

$ Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000089710122000472 Filed on May 06, 2022

Income Statement

Concept	2022 Q1	2021 Q1

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.31M	$18.71M
YoY Change	3.18%	36.97%
Cash & Equivalents	$10.23M	$10.03M
Short-Term Investments	$9.079M	$8.680M
Other Short-Term Assets	$1.297M	$754.0K
YoY Change	72.02%	-28.87%
Inventory	$30.05M	$20.66M
Prepaid Expenses	$779.0K	$901.0K
Receivables	$22.29M	$15.91M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$73.70M	$56.94M
YoY Change	29.43%	22.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.269M	$3.446M
YoY Change	-5.14%	12.5%
Goodwill	$1.366M	$1.366M
YoY Change	0.0%	0.0%
Intangibles	$351.0K	$303.0K
YoY Change	15.84%	8.21%
Long-Term Investments	$18.92M	$13.59M
YoY Change	39.21%	-10.53%
Other Assets	$3.746M	$4.490M
YoY Change	-16.57%	-8.18%
Total Long-Term Assets	$29.57M	$25.99M
YoY Change	13.75%	-8.84%
TOTAL ASSETS
Total Short-Term Assets	$73.70M	$56.94M
Total Long-Term Assets	$29.57M	$25.99M
Total Assets	$103.3M	$82.93M
YoY Change	24.52%	10.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.35M	$7.784M
YoY Change	58.61%	-4.98%
Accrued Expenses	$3.600M	$3.103M
YoY Change	16.02%	21.26%
Deferred Revenue	$1.089M	$687.0K
YoY Change	58.52%	25.36%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.91M	$12.40M
YoY Change	44.45%	3.04%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$187.0K	$143.0K
YoY Change	30.77%	-29.9%
Total Long-Term Liabilities	$187.0K	$143.0K
YoY Change	30.77%	-29.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.91M	$12.40M
Total Long-Term Liabilities	$187.0K	$143.0K
Total Liabilities	$18.10M	$15.78M
YoY Change	14.72%	-2.29%
SHAREHOLDERS EQUITY
Retained Earnings	$45.16M	$30.25M
YoY Change	49.25%	26.51%
Common Stock	$39.59M	$38.21M
YoY Change	3.61%	3.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$82.80M	$67.16M
YoY Change
Total Liabilities & Shareholders Equity	$103.3M	$82.93M
YoY Change	24.52%	10.31%

Cashflow Statement

Concept	2022 Q1	2021 Q1

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	CYBEROPTICS CORP
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000768411
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Entity File Number EntityFileNumber	0-16577
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1472057
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5900 Golden Hills Drive
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	MINNEAPOLIS
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55416
CY2022Q1	dei	City Area Code CityAreaCode	(763)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	542-5000
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2022Q1	dei	Trading Symbol TradingSymbol	CYBE
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7403683	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10226000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13684000	USD
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	9079000	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7327000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	385000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19821000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	30048000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Inventory Net InventoryNet	27602000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	779000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	808000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1297000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	864000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	73700000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	70106000	USD
CY2022Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	18918000	USD
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	17281000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3269000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3174000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	351000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	375000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	1366000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	1366000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1916000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2052000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3746000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3668000	USD
CY2022Q1	us-gaap	Assets Assets	103266000	USD
CY2021Q4	us-gaap	Assets Assets	98022000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	12346000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10275000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1089000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	599000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3600000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4418000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	878000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	17913000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16156000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	187000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	177000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2152000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2369000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	214000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	214000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	18916000	USD
CY2022Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue
CY2021Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7402683	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7402683	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7391906	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7393	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7391906	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	39587000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7581	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7463	shares
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-71000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-147000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-457000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-72000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	353000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	334000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	39052000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1942000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	45155000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41564000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-219000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-15000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	17000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2480000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1124000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2624000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	721000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	363000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	73000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	9353000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	11594000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	8379000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2929000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2761000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4701000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3888000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2082000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-432000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-204000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1237000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3591000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1441000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	634000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	82800000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	79106000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	103266000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	98022000	USD
CY2022Q1	us-gaap	Revenues Revenues	24246000	USD
CY2021Q1	us-gaap	Revenues Revenues	17732000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	12652000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3964000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1730000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	85000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	22000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4049000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1752000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	458000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	311000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3591000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1441000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.2
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	152000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	30000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	30000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	18000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	33000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-6000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2703000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	486000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-120000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-738000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-203000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-211000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	766000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2418000	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3184000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2597000	USD
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	7077000	USD
CY2021Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2767000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	491000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	650000	USD
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	29000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4413000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-854000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	183000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	57000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	182000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	11000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3458000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13684000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8399000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10031000	USD
CY2022Q1	us-gaap	Revenues Revenues	24246000	USD
CY2022Q1	cybe	Percentage Of Revenue Performance Obligations PercentageOfRevenuePerformanceObligations	1	pure
CY2021Q1	us-gaap	Revenues Revenues	17732000	USD
CY2021Q1	cybe	Percentage Of Revenue Performance Obligations PercentageOfRevenuePerformanceObligations	1	pure
CY2022Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	22000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	7000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	772000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	289000	USD
CY2022Q1	cybe	Contract With Customer Liability Deferred Warranty Revenue ContractWithCustomerLiabilityDeferredWarrantyRevenue	448000	USD
CY2021Q4	cybe	Contract With Customer Liability Deferred Warranty Revenue ContractWithCustomerLiabilityDeferredWarrantyRevenue	445000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2022Q1	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	351825	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.11
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11075	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	17.39
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	340750	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.13
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	245951	shares
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	178000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	339000	USD
CY2022Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	115000	USD
CY2021Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	90000	USD
CY2022Q1	cybe	Contract With Customer Liability And Deferred Revenue Revenue Recognized ContractWithCustomerLiabilityAndDeferredRevenueRevenueRecognized	293000	USD
CY2021Q1	cybe	Contract With Customer Liability And Deferred Revenue Revenue Recognized ContractWithCustomerLiabilityAndDeferredRevenueRevenueRecognized	429000	USD
CY2022Q1	cybe	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	22381000	USD
CY2022Q1	cybe	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	417000	USD
CY2022Q1	cybe	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	2778000	USD
CY2022Q1	cybe	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	88000	USD
CY2021Q4	cybe	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	15716000	USD
CY2021Q4	cybe	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	86000	USD
CY2021Q4	cybe	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	355000	USD
CY2021Q4	cybe	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2000	USD
CY2022Q1	cybe	Maximum Maturity Of Debt Securities MaximumMaturityOfDebtSecurities	P5Y
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	500000000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	43000000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2022Q1	cybe	Marketable Securities Classified As Cash Equivalents Cost MarketableSecuritiesClassifiedAsCashEquivalentsCost	4900000	USD
CY2021Q4	cybe	Marketable Securities Classified As Cash Equivalents Cost MarketableSecuritiesClassifiedAsCashEquivalentsCost	8800000	USD
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
CY2022Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	27997000	USD
CY2021Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	24608000	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2022Q1	cybe	Number Of Stock Based Compensation Plans NumberOfStockBasedCompensationPlans	3	plan
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
CY2022Q1	cybe	Share Based Compensation Arrangement By Share Based Payment Award Options Grants Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsForfeituresAndExpirationsInPeriod	0	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	2300000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	73000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	56000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	57901	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	28.21
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	2000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	27.96
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	55901	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	28.22
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	353000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	334000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2600000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M7D
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	79106000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	183000	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	353000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-432000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3591000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	82800000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	57000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	334000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-204000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1441000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	67156000	USD
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	19301000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	18013000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1703000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1655000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7681000	USD
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1083000	USD
CY2021Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	890000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1027000	USD
CY2021Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	851000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6859000	USD
CY2022Q1	us-gaap	Other Inventory Demo OtherInventoryDemo	1363000	USD
CY2021Q4	us-gaap	Other Inventory Demo OtherInventoryDemo	1075000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	30048000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	27602000	USD
CY2022Q1	cybe	Demonstration Inventory Useful Life DemonstrationInventoryUsefulLife	P36M
CY2022Q1	cybe	Accumulated Amortization Inventories AccumulatedAmortizationInventories	2800000	USD
CY2021Q4	cybe	Accumulated Amortization Inventories AccumulatedAmortizationInventories	2800000	USD
CY2022Q1	cybe	Amortization Expense Related To Demonstration Inventories AmortizationExpenseRelatedToDemonstrationInventories	142000	USD
CY2021Q1	cybe	Amortization Expense Related To Demonstration Inventories AmortizationExpenseRelatedToDemonstrationInventories	154000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1936000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2966000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1027000	USD
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	949000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	519000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	341000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	118000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	162000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3600000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4418000	USD
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	839000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	261000	USD
CY2021Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	272000	USD
CY2022Q1	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	64000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-40000	USD
CY2022Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	233000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	181000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	56000	USD
CY2022Q1	cybe	Earnings Per Share Dilutive Adjustment EarningsPerShareDilutiveAdjustment	-0.02
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3591000	USD
CY2021Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	39000	USD
CY2021Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	445000	USD
CY2020Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	344000	USD
CY2022Q1	us-gaap	Extended Product Warranty Accrual Period Increase Decrease ExtendedProductWarrantyAccrualPeriodIncreaseDecrease	124000	USD
CY2021Q1	us-gaap	Extended Product Warranty Accrual Period Increase Decrease ExtendedProductWarrantyAccrualPeriodIncreaseDecrease	147000	USD
CY2022Q1	cybe	Extended Product Warranty Accrual Amortization Of Deferred Revenue ExtendedProductWarrantyAccrualAmortizationOfDeferredRevenue	121000	USD
CY2021Q1	cybe	Extended Product Warranty Accrual Amortization Of Deferred Revenue ExtendedProductWarrantyAccrualAmortizationOfDeferredRevenue	106000	USD
CY2022Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	448000	USD
CY2021Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	385000	USD
CY2022Q1	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	317000	USD
CY2021Q1	us-gaap	Extended Product Warranty Accrual Noncurrent ExtendedProductWarrantyAccrualNoncurrent	104000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1942000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	351000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2264000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1889000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	375000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7393	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	146000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	150000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	54000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	1000	USD
CY2022Q1	us-gaap	Revenues Revenues	24246000	USD
CY2021Q1	us-gaap	Revenues Revenues	17732000	USD
CY2022Q1	cybe	Revenue Export Sales Percentage RevenueExportSalesPercentage	0.85	pure
CY2021Q1	cybe	Revenue Export Sales Percentage RevenueExportSalesPercentage	0.82	pure
CY2022Q1	cybe	Export Revenues ExportRevenues	20523000	USD
CY2021Q1	cybe	Export Revenues ExportRevenues	14467000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3591000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7293	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.2
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	170	shares
CY2021Q1	cybe	Earnings Per Share Dilutive Adjustment EarningsPerShareDilutiveAdjustment	-0.01
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1441000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7463	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	71000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	97000	shares
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-71000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-71000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-147000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-147000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-457000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-96000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-361000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-72000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-15000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-57000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-96000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-204000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1510000	USD
CY2022Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-432000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1942000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1102000	USD
CY2021Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-204000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	458000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	311000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.11	pure
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.18	pure
CY2022Q1	cybe	Need For Valuation Allowance Based On History Of Cumulative Losses NeedForValuationAllowanceBasedOnHistoryOfCumulativeLosses	P3Y

Files In Submission

Name	View Source	Status
0000897101-22-000472-index-headers.html	Edgar Link	pending
0000897101-22-000472-index.html	Edgar Link	pending
0000897101-22-000472.txt	Edgar Link	pending
0000897101-22-000472-xbrl.zip	Edgar Link	pending
cybe-20220331.htm	Edgar Link	pending
cybe-20220331.xsd	Edgar Link	pending
cybe-20220331_cal.xml	Edgar Link	unprocessable
cybe-20220331_def.xml	Edgar Link	unprocessable
cybe-20220331_htm.xml	Edgar Link	completed
cybe-20220331_lab.xml	Edgar Link	unprocessable
cybe-20220331_pre.xml	Edgar Link	unprocessable
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex32_3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

CYBEROPTICS CORP

2022 Q1 Form 10-Q Financial Statement

#000089710122000472 Filed on May 06, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission